MUKKA
Mukka Proteins financials
- Market cap
- ₹965 Cr
- Sector
- Fast Moving Consumer Goods
What Mukka Proteins Limited does
Mukka Proteins Limited processes pelagic fish into fishmeal, fish oil and fish-soluble paste for aquaculture, poultry, pet food and veterinary-pharma feed customers, exporting to 25+ countries. It has diversified into a Black Soldier Fly (BSF) insect-protein platform that converts municipal wet waste into insect meal, oil, compost, humic acid and briquettes, and separately undertakes municipal leachate management under long-term government contracts. It also runs an EU-approved frozen and value-added marine products business producing surimi, IQF and blast-frozen seafood (shrimp, squid, cuttlefish and other species) for export.
Segments
- Fish Protein
- Alternate Proteins (Insects Biotech)
- Waste Management & Environmental Solutions
- Frozen & Value-Added Marine Products
- Manufacturing units
- 24 (incl. third-party & job-work units); 16 owned in-house facilities across India & Oman
- Installed capacity — fishmeal, fish oil & fish soluble paste
- 2,91,720 MT/year
- Installed capacity — insect (BSF) protein
- 1,400 TPD (Mangaluru 200 TPD, Bengaluru 1,000 TPD, Kochi 200 TPD)
- Frozen & value-added marine products capacity
- 167 TPD freezing; 1,926 TPD cold storage
- Upcoming Oman facility capacity (fishmeal/fish oil/paste)
- 400 TPD
- Export presence
- 25+ countries
Quarterly results
Q1 FY27: revenue up 186.5%, net profit up 850.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 149 | 303 | 382 | 171 | 245 +64% | 654 +116% | 381 −0% | 490 +187% |
| EBITDA | 10 | 41 | 29 | 14 | 20 +100% | 45 +10% | 34 +17% | 47 +236% |
| Net profit | 1 | 27 | 14 | 2 | 7 +600% | 27 +0% | 21 +50% | 19 +850% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +11.7% 1Y
1Y: ₹28.8 on 10 Sept 2025 → ₹32.17. High ₹32.17 (11 Sept 2026), low ₹18.49 (30 Mar 2026).
Financials, as filed
Revenue grew 2.5% a year over 2 years, FY24 to FY26. Operating margin held at 7.8%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1.4k Cr | ₹1.0k Cr | ₹1.5k Cr |
| Operating profit | ₹103 Cr | ₹94 Cr | ₹113 Cr |
| Operating margin | 7.5% | 9.3% | 7.8% |
| Interest | ₹25 Cr | ₹38 Cr | ₹54 Cr |
| Depreciation | ₹12 Cr | ₹14 Cr | ₹16 Cr |
| Net profit | ₹74 Cr | ₹47 Cr | ₹57 Cr |
| Net margin | 5.4% | 4.7% | 3.9% |
| Cash from operations | ₹-150 Cr | ₹-112 Cr | ₹-111 Cr |
| Free cash flow | ₹-165 Cr | ₹-130 Cr | ₹-230 Cr |
| ROCE | 19.0% | 12.0% | 12.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹6 Cr | ₹22 Cr | ₹22 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
| Reserves | ₹61 Cr | ₹76 Cr | ₹126 Cr | ₹366 Cr | ₹414 Cr | ₹469 Cr |
| Borrowings | ₹159 Cr | ₹175 Cr | ₹262 Cr | ₹365 Cr | ₹610 Cr | ₹779 Cr |
| Other liabilities | ₹129 Cr | ₹119 Cr | ₹166 Cr | ₹179 Cr | ₹185 Cr | ₹343 Cr |
| Total liabilities | ₹355 Cr | ₹392 Cr | ₹575 Cr | ₹941 Cr | ₹1.2k Cr | ₹1.6k Cr |
| Fixed assets | ₹79 Cr | ₹83 Cr | ₹85 Cr | ₹85 Cr | ₹109 Cr | ₹194 Cr |
| Capital work in progress | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹33 Cr | ₹31 Cr |
| Investments | ₹12 Cr | ₹21 Cr | ₹21 Cr | ₹31 Cr | ₹40 Cr | ₹56 Cr |
| Other assets | ₹260 Cr | ₹289 Cr | ₹469 Cr | ₹825 Cr | ₹1.1k Cr | ₹1.3k Cr |
| Total assets | ₹355 Cr | ₹392 Cr | ₹575 Cr | ₹941 Cr | ₹1.2k Cr | ₹1.6k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +2.22 pp while DIIs trimmed −1.87 pp. The shareholder count shrank 12% to 1,27,922.
- Promoters
- 73.3%
- FIIs
- 1.7%
- Public
- 24.9%
Since Jun 2025
- Public +2.22 pp
- DIIs −1.87 pp
- FIIs −0.35 pp
How it drifted, 10 quarters
Over this window the public went from 18.2% to 24.9% — +6.7 pp.
Ownership split by quarter, oldest first. Mar '24: Promoters 73.3%, FIIs 6.5%, DIIs 2.0%, Public 18.2%.Jun '24: Promoters 73.3%, FIIs 5.1%, DIIs 2.5%, Public 19.1%.Sep '24: Promoters 73.3%, FIIs 2.8%, DIIs 2.0%, Public 21.8%.Dec '24: Promoters 73.3%, FIIs 2.6%, DIIs 2.0%, Public 22.1%.Mar '25: Promoters 73.3%, FIIs 2.6%, DIIs 2.0%, Public 22.1%.Jun '25: Promoters 73.3%, FIIs 2.1%, DIIs 1.9%, Public 22.7%.Sep '25: Promoters 73.3%, FIIs 1.7%, DIIs 1.7%, Public 23.3%.Dec '25: Promoters 73.3%, FIIs 1.7%, DIIs 0.2%, Public 24.8%.Mar '26: Promoters 73.3%, FIIs 1.7%, Public 25.0%.Jun '26: Promoters 73.3%, FIIs 1.7%, Public 24.9%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Umaya Infraventure Building Contracting L.L.C newly disclosed 0.00% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Mukka Proteins Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Mohammed Haris K | 30.23% | unchanged |
| K Mohammad Arif | 16.13% | unchanged |
| K Mohammed Althaf | 16.13% | unchanged |
| Kalandan Abdul Razak | 7.33% | unchanged |
| Umaiyya Banu | 3.50% | unchanged |
| Craft Emerging Market Fund Pcc- Elite Capital Fund FPI fund | 1.19% | unchanged |
| Mohammed Ayaan Haris | 0.00% | unchanged |
| Mohammed Sahim Haris | 0.00% | unchanged |
| Ainy Mariyam Haris | 0.00% | unchanged |
| S Abdul Majeed | 0.00% | unchanged |
| Khairunissa Mohammed | 0.00% | unchanged |
| Mohammed Sameer Abbas | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Mukka Proteins Limited
Guides on how to read this kind of business and the numbers that matter.